From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research”

dc.creatorHéctor Alejandro Cabrera Fuentes
dc.date.accessioned2018-10-18T20:12:53Z
dc.date.accessioned2022-10-13T22:15:36Z
dc.date.available2018-10-18T20:12:53Z
dc.date.available2022-10-13T22:15:36Z
dc.date.created2018-10-18T20:12:53Z
dc.identifier3008428
dc.identifier10.1007/s00395-016-0586-x
dc.identifierhttp://hdl.handle.net/11285/630319
dc.identifier111
dc.identifier6
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4225972
dc.publisherDr. Dietrich Steinkopff Verlag GmbH and Co. KG
dc.relationhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84991383711&doi=10.1007%2fs00395-016-0586-x&partnerID=40&md5=0aa423e5a69965e507c20dd7e6891b93
dc.relationInvestigadores
dc.relationEstudiantes
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceBasic Research in Cardiology
dc.subjecthigh density lipoprotein cholesterol
dc.subjecthigh mobility group B1 protein
dc.subjectmacrophage migration inhibition factor
dc.subjectmacrophage migration inhibition factor 2
dc.subjectpancreatic ribonuclease
dc.subjectprotein kinase B
dc.subjectreactive oxygen metabolite
dc.subjectSTAT3 protein
dc.subjecttoll like receptor 4
dc.subjecttroponin I
dc.subjecttroponin T
dc.subjecttumor necrosis factor
dc.subjectunclassified drug
dc.subjectvascular endothelial cadherin
dc.subjectatherectomy
dc.subjectatherogenesis
dc.subjectatherosclerosis
dc.subjectcardiac muscle cell
dc.subjectcardiovascular magnetic resonance
dc.subjectchronic kidney disease
dc.subjectcohort analysis
dc.subjectcomorbidity
dc.subjectcoronary artery bypass graft
dc.subjectdisease association
dc.subjectdisease course
dc.subjectdisseminated intravascular clotting
dc.subjectdrug eluting stent
dc.subjectEscherichia coli
dc.subjectheart infarction size
dc.subjectheart mitochondrion
dc.subjectheart protection
dc.subjectheart surgery
dc.subjecthemolytic uremic syndrome
dc.subjecthuman
dc.subjectimmunosuppressive treatment
dc.subjectimmunothrombosis
dc.subjectin vivo study
dc.subjectinnate immunity
dc.subjectinsulin dependent diabetes mellitus
dc.subjectmulticenter study (topic)
dc.subjectmyocardial ischemia reperfusion injury
dc.subjectnon ST segment elevation myocardial infarction
dc.subjectnonhuman
dc.subjectoxidative stress
dc.subjectpercutaneous coronary intervention
dc.subjectpilot study
dc.subjectprotein expression
dc.subjectprotein phosphorylation
dc.subjectrandomized controlled trial (topic)
dc.subjectretinopathy
dc.subjectReview
dc.subjectsepsis
dc.subjectsignal transduction
dc.subjectST segment elevation myocardial infarction
dc.subjectthrombosis
dc.subjectanimal
dc.subjectcardiology
dc.subjectcardiovascular disease
dc.subjectprocedures
dc.subjecttheranostic nanomedicine
dc.subjecttrends
dc.subjectAnimals
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.subjectHumans
dc.subjectTheranostic Nanomedicine
dc.titleFrom basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research”
dc.typeArtículo


Este ítem pertenece a la siguiente institución